Yes, rosuvastatin 20-40 mg is high-intensity statin therapy
Rosuvastatin at doses of 20-40 mg daily is definitively classified as high-intensity statin therapy, expected to lower LDL cholesterol by ≥50%. 1, 2, 3, 4
Statin Intensity Classification
According to the most recent 2025 ADA/ACC/AHA guidelines, statin intensity is categorized as follows:
High-Intensity Statins (≥50% LDL-C reduction):
- Atorvastatin 40-80 mg
- Rosuvastatin 20-40 mg
Moderate-Intensity Statins (30-49% LDL-C reduction):
- Atorvastatin 10-20 mg
- Rosuvastatin 5-10 mg
- Simvastatin 20-40 mg
- Pravastatin 40-80 mg
- Lovastatin 40 mg
- Fluvastatin XL 80 mg
- Pitavastatin 1-4 mg
Clinical Context
The distinction between rosuvastatin 5-10 mg (moderate-intensity) and 20-40 mg (high-intensity) is clinically significant:
For primary prevention in diabetes patients aged 40-75 with additional ASCVD risk factors, high-intensity statin therapy (rosuvastatin 20-40 mg) is recommended to achieve LDL-C <70 mg/dL 2
For secondary prevention in all patients with established ASCVD, high-intensity statin therapy (rosuvastatin 20-40 mg) should be used 1, 2, 5
Real-world data from the VOYAGER database confirms that rosuvastatin 20 mg and 40 mg consistently achieve ≥50% LDL-C reduction across different patient populations 6
Important Caveats
Asian patients require special consideration: initiate at 5 mg daily due to increased plasma concentrations, and carefully weigh risks versus benefits if doses above 20 mg are considered 2, 7
Patients with severe renal impairment (CrCl <30 mL/min not on hemodialysis) should start at 5 mg daily and not exceed 10 mg daily 7
The classification is consistent across all major guidelines (ADA 2025, ACC/AHA 2018/2019) and FDA labeling 2, 3, 4, 7.